(Q27682048)
Statements
Discovery of a novel class of exquisitely selective mesenchymal-epithelial transition factor (c-MET) protein kinase inhibitors and identification of the clinical candidate 2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol (PF-04217903) for the treatment of cancer (English)
J Jean Cui
Michele McTigue
Mitchell Nambu
Michelle Tran-Dubé
Mason Pairish
Hong Shen
Lei Jia
Hengmiao Cheng
Jacqui Hoffman
Phuong Le
Mehran Jalaie
Kevin Ryan
Neil Grodsky
Ya-li Deng
Max Parker
Sergei Timofeevski
Shinji Yamazaki
Shirley Aguirre
Qiuhua Li
Helen Zou
James Christensen
10 September 2012
Identifiers
2 references
2 references